Allergan, Inc today announced the U.S. Food and Drug Administration (FDA) has approved Botox for the treatment of headaches in adults with Chronic Migraine, Chronic migraine is defined as having a history of migraine and experiencing a headache on most days of the month.
The decision will allow doctors to use Botox to treat people who experience chronic migraine, a condition defined as one in which people have headaches on at least 15 days of the month.
Allergan will charge doctors $525 for a 100-unit vial, the same price charged to skin doctors who give Botox to fight wrinkles, a company spokeswoman said.
The Botox injection will be given every 12 weeks as multiple injections around the head and neck to try to dull future headache symptoms. Botox has not been proven to work on migraine headaches that happen 14 days or less per month or other types of headaches.
The FDA okayed Botox on company studies of more than 1,300 patients who received either a Botox injection or a dummy injection. Patients who received Botox reported fewer “headache days” than patients given the sham treatment. Allergan, which specializes in beauty and eye-care drugs, said approximately 3.2 million people in the U.S. have chronic migraines.
Doctors presently utilize a wide variety of medications to treat migraines, ranging from over-the-counter painkillers like Advil to prescription narcotics like codeine. Some patients also respond to changes in diet or lifestyle, such as reducing caffeine or stress. The World Health Organization (WHO) ranks migraine as the 19th most disabling disease.
The decision will allow doctors to use Botox to treat people who experience chronic migraine, a condition defined as one in which people have headaches on at least 15 days of the month.
Allergan will charge doctors $525 for a 100-unit vial, the same price charged to skin doctors who give Botox to fight wrinkles, a company spokeswoman said.
The Botox injection will be given every 12 weeks as multiple injections around the head and neck to try to dull future headache symptoms. Botox has not been proven to work on migraine headaches that happen 14 days or less per month or other types of headaches.
The FDA okayed Botox on company studies of more than 1,300 patients who received either a Botox injection or a dummy injection. Patients who received Botox reported fewer “headache days” than patients given the sham treatment. Allergan, which specializes in beauty and eye-care drugs, said approximately 3.2 million people in the U.S. have chronic migraines.
Doctors presently utilize a wide variety of medications to treat migraines, ranging from over-the-counter painkillers like Advil to prescription narcotics like codeine. Some patients also respond to changes in diet or lifestyle, such as reducing caffeine or stress. The World Health Organization (WHO) ranks migraine as the 19th most disabling disease.
No comments:
Post a Comment